Hoitt Jason — SEC Form 4 filings

SEC reporting owner CIK 1762572. 3 Form 4 filings on record with FilingPulse; latest filed 2026-03-19.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2026-02-19 to 2026-03-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Stoke Therapeutics, Inc. (STOK)Chief Patient Officer35 legs · 3,712 sh · $119,3114

Form 4 filings — Hoitt Jason

FiledFormIssuerReported transactionsSource
2026-03-194Stoke Therapeutics, Inc. (STOK)Sale (S): 1,033 @ $32.74 · Sale (S): 748 @ $33.38 · Sale (S): 1,762 @ $31.28 · Sale (S): 139 @ $31.79 · Sale (S): 30 @ $32.85EDGAR
2026-03-174Stoke Therapeutics, Inc. (STOK)Option exercise (M): 10,000 @ $0 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2026-02-194Stoke Therapeutics, Inc. (STOK)Grant/award (A): 72,000 (derivative) @ $0 · Grant/award (A): 48,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1762572 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →